High Potassium Intake Enhances the Inhibitory Effect of 11,12-EET on ENaC
- 1 October 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 21 (10), 1667-1677
- https://doi.org/10.1681/asn.2009111110
Abstract
High dietary potassium stimulates the renal expression of cytochrome P450 (CYP) epoxygenase 2C23, which metabolizes arachidonic acid (AA). Because the AA metabolite 11,12-epoxyeicosatrienoic acid (11,12-EET) can inhibit the epithelial sodium channel (ENaC) in the cortical collecting duct, we tested whether dietary potassium modulates ENaC function. High dietary potassium increased 11,12-EET in the isolated cortical collecting duct, an effect mimicked by inhibiting the angiotensin II type I receptor with valsartan. In patch-clamp experiments, a high potassium intake or treatment with valsartan enhanced AA-induced inhibition of ENaC, an effect mediated by a CYP-epoxygenase–dependent pathway. Moreover, high dietary potassium and valsartan each augmented the inhibitory effect of 11,12-EET on ENaC. Liquid chromatography/mass spectrometry showed that the rate of EET conversion to dihydroxyeicosatrienoic acids (DHET) was lower in renal tissue obtained from rats on a high-potassium diet than from those on a control diet, but this was not a result of altered expression of soluble epoxide hydrolase (sEH). Instead, suppression of sEH activity seemed to be responsible for the 11,12-EET–mediated enhanced inhibition of ENaC in animals on a high-potassium diet. Patch-clamp experiments demonstrated that 11,12-DHET was a weak inhibitor of ENaC compared with 11,12-EET, whereas 8,9- and 14,15-DHET were not. Furthermore, inhibition of sEH enhanced the 11,12-EET–induced inhibition of ENaC similar to high dietary potassium. In conclusion, high dietary potassium enhances the inhibitory effect of AA and 11,12-EET on ENaC by increasing CYP epoxygenase activity and decreasing sEH activity, respectively.Keywords
This publication has 38 references indexed in Scilit:
- Expression and phosphorylation of the Na+-Cl− cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1American Journal of Physiology-Renal Physiology, 2009
- Arachidonic acid cytochrome P450 epoxygenase pathwayJournal of Lipid Research, 2009
- Epoxyeicosatrienoic Acid Activates BK Channels in the Cortical Collecting DuctJournal of the American Society of Nephrology, 2009
- Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophyProceedings of the National Academy of Sciences of the United States of America, 2009
- Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor responseThe FASEB Journal, 2008
- Hydrolysis ofcis- andtrans-Epoxyeicosatrienoic Acids by Rat Red Blood CellsThe Journal of pharmacology and experimental therapeutics, 2008
- Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channelJCI Insight, 2006
- Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced HypertensionHypertension, 2005
- Salt-Sensitive Hypertension After Exposure to Angiotensin Is Associated With Inability to Upregulate Renal EpoxygenasesHypertension, 2003